Long-term administration of the fungus toxin, sterigmatocystin, induces intestinal metaplasia and increases the proliferative activity of PCNA, p53, and MDM2 in the gastric mucosa of aged Mongolian gerbils

Marshall BJ, Armstrong JA, Mcgechie DB, Glancy RJ. Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust. 1985;142:436–9.

Sakaki N, Momma K, Yamada Y, Tadokoro Y, Tajima T. Helicobacter pylori infection and the development of atrophic gastritis assessed by endoscopy. Eur J Gastroenterol Hepatol. 1992;4(Suppl 1):S85–7.

Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991;83:640–3.

Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.

Kato H, Sobue T, Katanoda K, Saito Y, Tsukuma H, Saruki N, et al. Cancer statistics in Japan ‘2008’. Tokyo: Center for Cancer Control and Information Services, National Cancer Center Japan; 2008. p. 62–9.

Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol. 2009;39:850–8.

Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005;11:791–6.

Atalla MM, Hassanein NM, EI-Beih AA, Youssef YA. Mycotoxin production in wheat grains by different Aspergilli in relation to different relative humidities and storage periods. Nahung/Food. 2003;47:6–10.

Chu FS. Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures. Mutat Res. 1991;259:291–306.

Xie TX, Wang FR, Wang JL, Zhang ZD. Sterigmatocystin induced adenocarcinoma of the lung and atypical hyperplasia of glandular stomach in mice. Chin J Cancer Res. 1991;3:31–4.

Truong Minh P, Fujino Y, Yoshimura T, Tokui N, Mizoue T, Yatsuya H, et al. Mortality and incidence rates of stomach cancer in the JACC Study. J Epidemiol. 2005;15(Suppl 2):S89–97.

Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984–92.

Shimamoto C, Hirata I, Hiraike Y, Takeuchi N, Nomura T, Katsu K. Evaluation of gastric motor activity in the elderly by electrogastrography and the 13C-acetate breath test. Gerontology. 2002;48:381–6.

Kusunoki M, Misumi J, Aoki K, Shimada T, Matsuo N, Sumiyoshi H, et al. Long-term administration of sterigmatocystin with drinking water in Helicobacter pylori-infected aged Mongolian gerbils enhances carcinogenesis in the gastric mucosa. J Phys Fit Nutr Immunol. 2009;19:8–16.

Terao K. Sterigmatocystin—a masked potent carcinogenic mycotoxin. J Toxicol. 1983;2:77–110.

Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642–8.

Ma F, Misumi J, Zhao W, Aoki K, Kudo M. Long-term treatment with sterigmatocystin, a fungus toxin, enhances the development of intestinal metaplasia of gastric mucosa in Helicobacter pylori-infected Mongolian gerbils. Scand J Gastroenterol. 2003;4:360–9.

Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol. 1997;151:1695–703.

Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, et al. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer. Pathol Res Pract. 1997;193:767–75.

Xie TX, Misumi J, Aoki K, Zhao WY, Liu SY. Absence of p53-mediated G1 arrest with induction of MDM2 in sterigmatocystin-treated cells. Int J Oncol. 2000;17:737–42.

Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol. 1988;83:504–9.

Ma F, Zhao W, Kudo M, Aoki K, Misumi J. Inhibition of vacuolation toxin activity of Helicobacter pylori by iodine, nitrite and potentiation by sodium chloride, sterigmatocystin and fluoride. Toxicol In Vitro. 2002;16:531–7.

Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998;58:4255–9.

Shousha S, El-Sherif AM, El-Guneid A, Arnaout AH, Murray-lyon IM. Helicobacter pylori and intestinal metaplasia: comparison between British and Yemeni patients. Am J Gastroenterol. 1993;88:1373–6.

Shimizu T, Usuda N, Yamanda T, Sugenoya A, Iida F. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer. 1993;71:2807–12.

Filipe MI, Mendes R, Lane DP, Morris RW. Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody to PCNA. Histopathology. 1993;22:349–54.

Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. 1993;8:307–18.

Hsu PI, Lai KH, Chien EJ, Lin CK, Lo GH, Jou HS, et al. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Anticancer Res. 2000;20:1221–8.

Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer. 1996;69:28–33.

Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996;274:948–53.

Fuchs SY, Adler V, Buschmann T, Wu X, Ronai Z. Mdm2 association with p53 targets its ubiquitination. Oncogene. 1998;17:2543–7.

Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992;69:1237–45.

Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature. 1995;375:694–8.

Dubs-Poterszman MC, Tocque B, Wasylyk B. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene. 1995;11:2445–9.

Martin K, Trouche D, Hagemeier C, Sørensen TS, La Thangue NB, Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature. 1995;375:691–4.

Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem. 1998;273:1–4.

Schmiedt RA, Mills JH, Adams JC. Tuning and suppression in auditory nerve fibers of aged gerbils raised in quiet or noise. Hear Res. 1990;45:221–6.

Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, et al. Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol. 1999;154:951–60.

Kimura K. Chronological transition of the fundic–pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology. 1972;63:584–92.